Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical Research

Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical Research Cardiology and Therapy Broadwin, C., Azizi, Z., Rodriguez, F. 2023

Abstract

Approximately one-third of clinical trials fail to meet their recruitment goals, which can cause costly delays to sponsors and compromise the scientific integrity and generalizability of a trial. Inadequate recruitment and retention of patient groups who have the disease under investigation may produce insufficient medical knowledge about the therapeutic effects of drugs or products for the population at large. It is essential to address these issues to ensure that certain groups are not unduly subjected to disproportionate risks or denied the benefits of research. This commentary will present opportunities for clinical trialists to use emerging technologies and decentralized approaches to improve clinical trial recruitment, mitigate disparities, and improve individual and population-level outcomes within cardiovascular medicine.

View details for DOI 10.1007/s40119-023-00311-y

View details for PubMedCentralID 9072305